ORP-100 S

N/A

Report date: 2024/07/02 14:10:38

Base Information

Drug NameORP-100 S
Drug Alias NameTheraduxORP-100ORP-100S
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionThioredoxin stimulants
TargetsThioredoxin
Therapy Area/IndicationsInflammationBronchiectasisCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Jewish Medical & Research Center
China Registration ClassN/A

Develop Information

Active CompaniesOrpro Therapeutics
Inactive CompaniesN/A
Active IndicationsInflammationBronchiectasisCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A